CEL-SCI to Present at the ThinkEquity Conference

09:00 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive Officer, will be presenting at the ThinkEquity Conference in New York, NY on Thursday, May 2, ...

Other Sources for this Article

Gavin de Windt
CEL-SCI Corporation
(703) 506-9460


More From BioPortfolio on "CEL-SCI to Present at the ThinkEquity Conference"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...